BIND BIOSCIENCES, INC
Profile
Company Names
BIND BIOSCIENCES, INC
BIND BIOSCIENCES INC
Addresses
325 VASSAR STREET, CAMBRIDGE, MA 02139
64 SIDNEY STREET, CAMBRIDGE, MA 02139
Phone Numbers
6174913400
6174910351
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2006
State Incorporated:
DELAWARE
Total Amount Raised:
$51,415,810.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-01-25
$8,697,684.00
$20,250,000.00
$11,552,316.00
Equity
3
2011-11-07
$25,547,174.00
$47,297,179.00
$21,750,005.00
Equity
2
2011-09-28
$4,750,000.00
$4,750,000.00
$0.00
Debt
1
2010-06-14
$12,420,952.00
$12,420,952.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NOUBAR
AFEYAN
DIRECTOR
OMID
FAROKHZAD
DIRECTOR
OMID
C.
FAROKHZAD
DIRECTOR
ANDREA
FRANZ
EXECUTIVE OFFICER
PETER
BARTON
HUTT
DIRECTOR
BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| BLEND BIOSCIENCES, INC.
| Q HOLDINGS, INC.
| BLEND THERAPEUTICS, INC.
| BIND BIOSCIENCES, INC
| LIVING PROOF INC
| SERES HEALTH, INC.
| FLEX PHARMA, INC.
| PRONUTRIA BIOSCIENCES, INC.
| SUNEVA MEDICAL INC.
| AXCELLA HEALTH INC.
| WHOLE BIOME INC.
| RUBIUS THERAPEUTICS, INC.
| CEREHEALTH CORP
| ATELERIX LIFE SCIENCES INC.
| COLABS INT-L, CORP.
DANIEL
KOERWER
EXECUTIVE OFFICER
ROBERT
S
LANGER
DIRECTOR
ROBERT
S.
LANGER, JR.
DIRECTOR
DANIEL
S.
LYNCH
DIRECTOR
SCOTT
MINICK
EXECUTIVE OFFICER, DIRECTOR
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
AMIR
H.
NASHAT
DIRECTOR
EDWARD
SCHNIPPER
EXECUTIVE OFFICER
JAMES
WRIGHT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

